A shadow market for unapproved slimming medications is propelled by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.
Experimental Drug Acquiring Traction Via Social Media
Retatrutide, which is still in clinical trials, is being promoted by online personalities for its alleged weight-reducing effects. Followers are encouraged to contact these accounts privately for source information, while also obtaining promotional offers.
Thriving Trade on Messaging Platforms
Additionally, a robust market exists on messaging services, where communities with thousands of members share comparison photos, administration instructions and claims of next-day UK delivery. Vendors market the drug there before directing customers to other platforms for purchases.
Learning About Retatrutide
Retatrutide is an experimental injection developed by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and glucagon. Early trials suggest it could assist patients lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.
Medical Experts Voice Concerns
However, doctors and pharmacists have cautions that the sale of what remains an unlicensed drug in the UK is worrisome and could lead to users administering products of unknown origin.
Some professionals stated the popularity for the experimental drug could be connected to the rising price of licensed weight loss products such as Mounjaro.
Regulatory Position and Implementation
Marketing retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unapproved medication that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Some content creators attempt to circumvent the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still violate pharmaceutical, marketing, and consumer regulations, risking penalties, legal action or prison.
Platform Response and Material Elimination
Based on the social media company, the service has removed violative material and prohibited associated hashtags and query recommendations. The company stated it was committed to keeping the service safe and allocating resources in strengthening enforcement strategies.
Digital Marketplace Operations
Investigations also found communities with up to 9,000 participants selling the experimental drug using the platform's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” instantly displays channels with numerous of members, filled with photos of slimming results, positive testimonials and step-by-step instructions for mixing or injecting at home.
Within moments of joining one group, a seller shared WhatsApp details, where most purchases take place. The seller sent an guidebook and promised shipping within 48 hours. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None inquired about body mass, health issues or previous experience.
Item Details and Costs
Inside these groups, messages show dark colored packages with Royal Mail stickers, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, mixed at residence with sterile water, or pre-filled pens usually priced at £160 for 20mg. When questioned how long a pen should be used, sellers give conflicting responses varying between a few weeks to “depends on your body”.
Platform Moderation and Safety Actions
A spokesperson for the messaging service stated it actively moderated dangerous material on its service including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“People are administering materials they cannot confirm. Although the science behind retatrutide is sound, these online products may not contain what they advertise,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of an online medical service linked the increase in demand to current price rises for authorized slimming drugs such as Mounjaro. “With prices increasing, individuals are using social media. But counterfeit injections are highly risky. You cannot know what’s inside or whether the environment they were made in was sterile,” she said.
Her team has already encountered patients injured by self-injection from unverified suppliers. “We recognize the frustration, but purchasing from Telegram or communication platforms is taking chances with your health,” said the doctor. “These materials could be impure or improperly measured.”
Manufacturer Statement
A representative from Eli Lilly said the substance was in third stage research studies and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they explained, adding that any product “falsely representing itself as a Lilly experimental substance not yet authorized … may subject users to potentially significant health risks”.
